Literature DB >> 22826096

Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review.

Wei Huang1, Frederick A Anderson, Frederick A Spencer, Alexander Gallus, Robert J Goldberg.   

Abstract

Venous thromboembolism (VTE) prophylaxis is suboptimal in American hospitals despite long-standing evidence-based recommendations. Data from observational studies indicate a lower uptake of effective prophylaxis in patients hospitalized with medical versus surgical conditions. Reluctance to use prophylaxis in medical patients has been attributed to difficulty in identifying at-risk patients and balancing risks of bleeding against occurrence of VTE. Several risk-assessment models (RAMs) have been proposed to assist physicians in identifying non-surgical patients who need prophylaxis. We conducted a systematic review of published RAMs, based on objective criteria, to determine whether any RAM is validated sufficiently to be employed in clinical practice. We identified 11 RAMs, six derived from primary data and five based on expert opinion. The number, types, and strength of association of VTE risk predictors were highly variable. The variability in methods and outcome measurement precluded pooled estimates of these different models. Published RAMs for VTE lack generalizability and adequate validation. As electronic health records become more ubiquitous, validated dynamic RAMs are needed to assess VTE risk at the point-of-care in real time.

Entities:  

Mesh:

Year:  2013        PMID: 22826096     DOI: 10.1007/s11239-012-0780-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  32 in total

1.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

3.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

Authors:  S H Downs; N Black
Journal:  J Epidemiol Community Health       Date:  1998-06       Impact factor: 3.710

Review 4.  Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.

Authors:  Alexander T Cohen; Raza Alikhan; Juan I Arcelus; Jean-François Bergmann; Sylvia Haas; Geno J Merli; Alex C Spyropoulos; Victor F Tapson; Alexander G G Turpie
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

5.  Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients.

Authors:  Scott C Woller; Scott M Stevens; Jason P Jones; James F Lloyd; R Scott Evans; Valerie T Aston; C Gregory Elliott
Journal:  Am J Med       Date:  2011-10       Impact factor: 4.965

6.  Risk assessment models for cancer-associated venous thromboembolism.

Authors:  Mrinal Dutia; Richard H White; Ted Wun
Journal:  Cancer       Date:  2011-11-15       Impact factor: 6.860

7.  Electronic alerts to prevent venous thromboembolism among hospitalized patients.

Authors:  Nils Kucher; Sophia Koo; Rene Quiroz; Joshua M Cooper; Marilyn D Paterno; Boris Soukonnikov; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

Review 9.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

Review 10.  Risk factors for venous thromboembolism.

Authors:  Frederick A Anderson; Frederick A Spencer
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

View more
  10 in total

Review 1.  A systematic review of mobility/immobility in thromboembolism risk assessment models for hospitalized patients.

Authors:  Fan Ye; Carolyn Stalvey; Matheen A Khuddus; David E Winchester; Hale Z Toklu; Joseph J Mazza; Steven H Yale
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

2.  Risk factors for pulmonary embolism in patients preliminarily diagnosed with community-acquired pneumonia: a prospective cohort study.

Authors:  Yunfeng Zhang; Qixing Zhou; Ying Zou; Xiaolian Song; Shuanshuan Xie; Min Tan; Guoliang Zhang; Changhui Wang
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

3.  Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews.

Authors:  Andrea J Darzi; Allen B Repp; Frederick A Spencer; Rami Z Morsi; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Kenneth A Bauer; Allison E Burnett; Mary Cushman; Francesco Dentali; Susan R Kahn; Suely M Rezende; Neil A Zakai; Arnav Agarwal; Samer G Karam; Tamara Lotfi; Wojtek Wiercioch; Reem Waziry; Alfonso Iorio; Elie A Akl; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-10-13

Review 4.  Thrombosis in the setting of cancer.

Authors:  Michael B Streiff
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

5.  Derivation of a risk assessment model for hospital-acquired venous thrombosis: the NAVAL score.

Authors:  Marcos de Bastos; Sandhi M Barreto; Jackson S Caiafa; Tânia Boguchi; José Luiz Padilha Silva; Suely M Rezende
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

6.  Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment.

Authors:  Andrea J Darzi; Samer G Karam; Frederick A Spencer; Alex C Spyropoulos; Lawrence Mbuagbaw; Scott C Woller; Neil A Zakai; Michael B Streiff; Michael K Gould; Mary Cushman; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Federico Germini; Marta Rigoni; Arnav Agarwal; Rami Z Morsi; Elie A Akl; Alfonso Iorio; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-06-23

7.  Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study.

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Alexander T Cohen; Frederick A Spencer
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

8.  External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.

Authors:  David Rosenberg; Ann Eichorn; Mauricio Alarcon; Lauren McCullagh; Thomas McGinn; Alex C Spyropoulos
Journal:  J Am Heart Assoc       Date:  2014-11-17       Impact factor: 5.501

Review 9.  Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.

Authors:  Anna K Jönsson; Johan Schill; Hans Olsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

10.  Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis.

Authors:  Alex C Spyropoulos; Concetta Lipardi; Jianfeng Xu; Colleen Peluso; Theodore E Spiro; Yoriko De Sanctis; Elliot S Barnathan; Gary E Raskob
Journal:  TH Open       Date:  2020-03-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.